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1. Introduction 
Atherosclerosis exhibits many inflammatory characteristics, in which macrophages and  
T-lymphocytes are found at the shoulder region of atherosclerotic plaque, and are associated 
with its rupture and thrombosis (Libby et al. 2010).  On the other hand, abdominal aortic 
aneurysm (AAA) shows distinct histological features; inflammatory cell infiltration was 
observed predominantly at the outer media and adventitia (Michel et al. 2010).  Several 
experimental studies have suggested important roles of inflammatory cells (macrophages, 
T-lymphocytes and neutrophils) in AAA development (Longo et al. 2002; Xiong et al. 2004; 
Eliason et al. 2005).  Mast cell, unique effector components of the immune system, play a 
critical role in defending hosts against pathogens by releasing a number of 
immunoregulatory mediators (Marshall & Jawdat 2004).  Mast cells synthesize a number of 
substances, which include histamine, heparin, tryptase, chymase, carboxypeptidase, 
cathepsin G, leukotriene C4, prostaglandin D2, tumor necrosis factor-α and interleukin (IL)-
4,-5,-6,-13, some of which are stored in secretory vesicles (Krishnaswamy et al. 2006).  
Recently, mast cells have been recognized not only to be involved in host defense but also to 
initiate the inflammatory response by recruiting macrophages and T-lymphocytes (von 
Stebut et al. 2003; Henz et al. 2001) and by releasing pro-inflammatory cytokines, growth 
factors, angiogenic mediators and proteases (Krishnaswamy et al. 2006).  Specifically, 
tryptase and chymase have been examined for their unique biological actions to modulate 
extracellular matrix formation and induce apoptosis of vascular smooth muscle cells (Cairns 
& Walls 1997; Leskinen et al. 2001; Tchougounova et al. 2005).  In this chapter, we 
characterize mast cell density and distribution in the human aneurysmal abdominal aorta, 
compared with atherosclerotic abdominal aorta, and discuss the potential role of this type of 
cell to understand the pathophysiology of AAA.     
2. Materials and methods 
This study was approved by the Human Investigation Review Committee of the University 
of Miyazaki (No. 99) and conformed with the principles outlined in the Declaration of 
Helsinki (World Medical Association Declaration of Helsinki. 1997).   
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2.1 Human tissue preparation 
Aneurysmal tissues were obtained from the anterior side of aortic walls of 60 Japanese 
suffering from AAA associated with atherosclerosis during elective repair surgery. AAA 
tissues were fixed in 10 % formalin or frozen in liquid nitrogen immediately after resection. 
Aortic tissues with various degrees of atherosclerosis were collected from the anterior side of 
the aorta at autopsy performed within 6 hours postmortem: 26, early stage atherosclerosis 
including diffuse intimal thickening or fatty streak; 30, advanced atherosclerosis formed by an 
extracellular lipid core (Stary et al. 1995). Hypertension was defined as a blood pressure 
>140/90 mm Hg or the need for antihypertensive medication. Diabetes mellitus was defined 
as fasting plasma glucose 126 mg/dL or higher and/or two-hour postprandial plasma glucose 
readings of 200 mg/dL or higher and/or the need for medicine in the medical records.   
2.2 Immunohistochemistry   
Single Staining: Aortic tissues fixed in 10% formalin were embedded in paraffin wax.  The 
tissue sections (3 µm thick) were microwaved at 95 oC for one hour in 10 mmol/L citrate 
buffer (pH 6.0) to stain mast cell tryptase, prior to incubation with the primary antibody.  
The sections were incubated at 4 oC overnight with the monoclonal antibody against 
tryptase (80 µg/mL, Clone AA1; DAKOcytomation), followed by incubation with 
horseradish peroxidase-labeled polymer conjugated secondary antibody (Dako Envision+ 
System) for 30 min at room temperature.  Immunoreactivity was visualized with 3,3’-
diaminobenzidine (Dako), counterstained with Mayer’s hematoxylin.  For IL-4 staining, 
frozen sections of AAA tissues were fixed in acetone and incubated with the monoclonal 
antibody against human IL-4 (10 µg/mL, clone 3007.11; R&D Systems, Inc.).   
Double Staining: To identify the phenotype of mast cells in aortic tissues, double staining was 
performed using a Histofine kit (Nichirei, Tokyo, Japan) according to the manufacturer’s 
instructions.  In double staining of tryptase (80 µg/mL, Clone AA1; DAKOcytomation) and 
chymase (1:100, Clone CC1; abcam), enzymatic activity of alkaline phosphatase for tryptase 
was visualized with new fuchsin in red (New Fuchsin Kit; Nichirei) and for chymase with 3, 3’, 
5, 5’-tetramethylbenzidine in blue (TMB substrate kit; Vector Laboratories).  
2.3 Morphometric analysis 
Mast cell numbers in at least 10 microscopic fields were counted at a magnification of x400 
and expressed as a density (cells per mm2) in the intima, outer media and adventitia of early 
(diffuse intimal thickening and fatty streak), advanced atherosclerotic abdominal aorta and 
AAA. In counting the cell number, the intima was defined as the region of the arterial wall 
from the endothelial surface to the luminal margin of the media;(Stary et al. 1992) however, 
the internal elastic lamina becomes unclear or absent in the advanced atherosclerotic aorta, 
so we counted mast cells located on the luminal side of atheromatous plaques. On the other 
hand, the adventitia was defined as the area outside the external elastic lamina and inside 
the border of inner dense and outer loose connective tissues, and the number of cells in the 
outer media and adventitia was combined because the external elastic lamina was mostly 
unclear in AAA specimens. Capillary vessel number positive for CD34 antigen was also 
evaluated in the outer media and adventitia, and was expressed as a density (/mm2). 
2.4 Western blot 
Denatured protein extract (30 µg) from the AAA and non-dilated atherosclerotic aorta was 
subjected to sodium dodecyl sulfate-polyacrylamide gel as described (Tsuruda et al. 2008).  
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The separated proteins electrically transferred onto polyvinylidene difluoride (PVDF) 
membranes were incubated with anti-mouse monoclonal IL -4 antibody (2 µg/mL, clone 
3007.11; R&D Systems, Inc.), followed by incubation with horseradish peroxidase-coupled 
second antibody.  Immunoreactive bands were visualized by the ECL Plus detection kit 
(Amersham), and intensities of the bands were analyzed densitometrically (Chemi DocTM 
Documentation System; BIO-RAD).  
3. Statistical analysis 
All data were analyzed with JMP 7.0.1 and GraphPad prism 5.  Comparisons between 
groups were assessed with the chi-square test or Kruskal-Wallis test, and the mast cell 
density and capillary number were correlated with the Spearman rank correlation 
coefficient test.  Protein expression between the two groups was analyzed with Student’s t-
test.  The data are expressed as the mean ± SEM or as the median with the quartile range, 1.5 
interquartile and outlying values.  Statistical significance was accepted at p<0.05.   
4. Results 
4.1 Patients’ characteristics 
Clinical parameters of the patients enrolled in this study are shown in the Table 1.  The 
advanced atherosclerosis and AAA groups were significantly older than the early stage 
atherosclerosis group, but there was no difference in age between AAA patients and those 
with advanced atherosclerosis.  The AAA group showed a significantly higher rate of 
hypertension than the early or advanced atherosclerosis group, whereas the ratio of diabetes 































Table 1. Patients’ characteristics.  Data are expressed as the mean ±SEM.  *p<0.01, **p<0.0001 
vs. early stage of atherosclerosis, ##p<0.0001 vs. advanced atherosclerosis 
4.2 Mast cell density in atherosclerotic abdominal aorta and AAA 
Figure 1 shows representative pictures of tryptase-positive mast cells at the intima and outer 
media and adventitia of early atherosclerosis (diffuse intimal thickening, DIT), advanced 
atherosclerosis and AAA.  As shown in Figure 2A, the density of mast cells at the intima 
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tended to decrease according to the degree of atherosclerosis, and was further diminished in 
AAA.  On the other hand, the cell number significantly increased at the outer media and 
adventitia of the AAA group, compared with those in the early or advanced atherosclerotic 
aorta (Figure 2B).   
 
 
Fig. 1. Representative pictures of tryptase-positive mast cells at intima and outer media and 
adventitia of early atherosclerosis (diffuse intimal thickening, DIT), advanced 
atherosclerosis and AAA.  Scale bar, 200 µm. 
 
 
Fig. 2. Mast cell density in early or advanced atherosclerosis and AAA.  Number of tryptase-
positive mast cells was counted at intima (A) and outer media and adventitia (B), respectively 
in early (n=26) or advanced (n=30) atherosclerosis and AAA (n=60). Data are expressed as the 
median with the quartile range, 1.5 interquartile and outlying values. *p<0.05, **p<0.01 vs. 
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4.3 Phenotype of mast cells in AAA 
Figure 3A-C illustrate the representative pictures of the mast cell phenotype in the AAA 
specimens.  As shown in Figure 3D, most of the mast cells distributed at the outer media 
and adventitia of AAA were positive both for tryptase and chymase (97.9%), while the 
remainder of the mast cell subtypes, tryptase-positive/chymase-negative (0.27%) or 
tryptase-negative/chymase-positive (1.9%) were a minor population.  The proportion of 
mast cell phenotypes was similar in early or advanced atherosclerotic aortae. 
 
 
Fig. 3. Phenotype of mast cells in early or advanced atherosclerosis and AAA.  
Representative pictures of tryptase-positive/chymase-negative (A), tryptase-
negative/chymase-positive (B) and tryptase-positive/chymase-positive mast cells (C).  Scale 
bar, 20 µm.  D, Percentage of mast cell phenotype in early (n=10) or advanced (n=5) 
atherosclerosis and AAA (n=26).   
4.4 Expression and distribution of IL-4 in AAA 
Figure 4A illustrates that the protein expression of IL-4 was significantly increased in AAA 
compared to the atherosclerotic aorta.  The immunoreactivity of IL-4 was widely distributed 
in the endothelial cells of microvessels and fibroblast-like cells at the outer media and 
adventitia of AAA (Figure 4B).   
4.5 Correlation between numbers of capillary vessel and mast cell  
Figure 5A shows that the number of capillary vessels distributed at the outer media and 
adventitia (so called “vasa vasorum”) was significantly increased in the advanced 
atherosclerotic aorta group compared with the early stage of atherosclerosis; however, the 
number did not change significantly between advanced atherosclerosis and AAA.  As 
shown in Figure 5B, mast cell density correlated with the capillary vessel number at the 
outer media and adventitia of all cases (n=116, r=0.349, p=0.0001). 
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Fig. 4. Protein expression of IL-4 and its distribution in AAA specimen.  A, Western blot for 
IL-4 in non-dilated atherosclerotic aorta (n=5) and AAA (n=6). Arrows indicate the mono-
form (18 kDa) and dimer (36 kDa) of IL-4, respectively.  The two forms of IL-4 expression 
were combined to present the data.  Data are expressed as the mean ± SEM.  *p<0.05 vs. 




























































































Fig. 5. A, Capillary vessel number determined by CD34-positive staining in the outer media 
and adventitia of early or atherosclerosis and AAA.  Data are expressed as the median with 
the quartile range, 1.5 interquartile and outlying values.  B, Correlation between numbers of 
mast cells and capillary vessels in the outer media and adventitia in early or advanced 
atherosclerosis and AAA (n=116, r=0.3494, p=0.0001).   
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Up to 8 % of men older than 65 years harbor AAA, and it is associated with several risk factors, 
such as smoking and hypertension (Nordon et al. 2010).  AAA progresses asymptomatically 
and patients with AAA eventually die due to rupture.  At the tissue level, inadequate 
remodeling of the extracellular matrix in aortic walls appears to be involved in the 
development, progression or rupture of AAA (Kadoglou & Liapis 2004; Choke et al. 2005; 
Longo et al. 2002; Xiong et al. 2004; Daugherty & Cassis 2004; Brown & Powell 1999; Singh et 
al. 2001; Freestone et al. 1995); however, to date, the underlying mechanism is not fully 
understood and there is no effective pharmacological therapy to inhibit/reverse enlargement 
of the aneurysmal aorta in humans.  The immune system is assumed to participate because of 
the inflammatory infiltration of macrophages and T lymphocytes that can produce enzymes 
degrading the extracellular matrix at the outer media and adventitia of human and 
experimental AAA (Longo et al. 2002; Ocana et al. 2003; Xiong et al. 2004).  
As a component of the immune system, mast cells are widely distributed throughout the body 
and have an important role in defending hosts against pathogens.  In the cardiovascular 
tissues, this type of cell is present at the intima of normal/fatty streak (Kaartinen et al. 1994), 
whereas it is more prominent at the adventitia of atherosclerotic aorta (Atkinson et al. 1994) 
and in the vulnerable plaques of atherosclerotic coronary and carotid arteries (Kaartinen et al. 
1998; Jeziorska et al. 1997).  Our data support a previous study (Kaartinen et al. 1994) which 
shows that mast cells at the intima decreased according to the degree of atherosclerosis, 
assuming that a loss of endogenous heparin production by mast cells stimulates pro-coagulant 
activity on atherosclerotic plaques.  More importantly, we demonstrated that the cell number 
was significantly increased at the outer media and adventitia of AAA, compared with either 
the early or advanced stage of atherosclerosis.  The proportion of activated mast cells (seen as 
“degranulation”) has been reported to be frequently observed in the adventitia of AAA 
compared to in advanced atherosclerosis (15±2 % vs. 0.4±0.3% total number of mast cells) 
(Tsuruda et al. 2008).  Thus, mast cells distributed “outside of aortic wall” appear to be 
associated with the AAA pathogenesis.   
Mast cells mature with tissue-specific phenotypes from circulating multipotent haematopoietic 
progenitor cells in response to signals communicated by quiescent microvascular environment 
cells where they become resident (Krishnaswamy et al. 2006).  Stem cell factor (SCF), a ligand 
for the proto-oncogene c-kit, is widely produced in various types of cells, such as fibroblasts 
(Nocka et al. 1990), endothelial cells and stromal cells (Heinrich et al. 1993), and is the main 
factor for the growth and differentiation of mast cells (Zsebo et al. 1990).  Circulating mast cell 
precursor has been reported to mature in tissues by SCF (Zsebo et al. 1990) and other cytokines 
such as IL-4 (Conti et al. 2003; Yanagida et al. 1995).  In accordance with the report (de Paulis et 
al. 1999), we have shown that the immunoreactivity of SCF was detected in the cytoplasm of 
mast cells (Tsuruda et al. 2008), suggesting autocrine or paracrine regulation of differentiation 
and maturation of cells in aortic tissues.  Schönbeck et al. (2002) showed the augmented 
expressions of IL-4 and IL-10 in inflammatory cells of AAA tissues.  Importantly, these 
cytokines enhanced the growth-promoting effect of SCF on mast cells (Conti et al. 2003; 
Yanagida et al. 1995), and we further demonstrated that IL-4 was widely present in the 
endothelial cells of microvessels and fibroblast-like cells in AAA specimens.  In contrast, we 
could not detect IL-10 expression in AAA tissues in this study (data not shown).  It seems 
likely that mast cells can mature or differentiate in the aneurysmal aortic wall, at least partly 
through SCF and IL-4 stimulation.   
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Human mast cells exhibit tissue-specific functional heterogeneity; they are divided 
conventionally into two different phenotypes depending on the proteases in their secretory 
vesicles.  In this study, the majority of mast cells distributed at the outer media and 
adventitia of AAA were positive both for tryptase and chymase.  One of the 
histopathological features of AAA is the degeneration of the media by apoptosis of smooth 
muscle cells (Lopez-Candales et al. 1997) and fragmentation of elastic fibers digested by 
matrix metalloproteinase (MMP) (Baxter et al. 1994), resulting in loss of integrity to maintain 
the architecture of the aortic wall.  Mast cell tryptase stimulates fibroblast proliferation 
(Cairns & Walls 1997) as well as MMP-1,-3 activation (Johnson et al. 1998).  On the other 
hand, mast cell chymase may have a wide range of actions in AAA tissues: induction of 
apoptosis of smooth muscle cells (Leskinen et al. 2001), conversion of angiotensin I to 
angiotensin II (Takai et al. 1999) and of pro-MMP-2 and -9 to the mature forms 
(Tchougounova et al. 2005), whereas mast cells themselves are found to express MMPs-2 
and 9 (Fang et al. 1999).  We have reported that interferon-γ produced from mast cells 
stimulated MMP-9 synthesis by macrophages in the co-culture (Tsuruda et al. 2008).  
Angiogenesis appears to be another important histopathological characteristic of AAA (Paik 
et al. 2004; Reeps et al. 2009).  Mast cells are capable of synthesizing factors associated with 
angiogenesis (Hiromatsu & Toda 2003), and indeed, are often positioned around capillary 
vessels.  We found a positive correlation between mast cell density and capillary number at 
the adventitial layer, speculating that mast cells might contribute to initiate the 
inflammatory response by stimulating the growth of the vasa vasorum, and thereby recruit 
macrophages and T-lymphocytes from outside the aortic wall (Satta et al. 1998; Reeps et al. 
2009).  However, it remains to be elucidated whether angiogenesis itself is relevant to AAA 
development, because the vessel number was statistically insignificant between AAA and 
advanced atherosclerosis in this study.  Based upon the observation in human tissues, we 
propose that mast cells infiltrating at the outer media and adventitia of the AAA wall 
contribute to the development or progression of aneurysm formation, coordinating with 
other inflammatory cells.  Furthermore, the inhibition of mast cell accumulation, maturation 
and activation in the aortic wall with a mast cell stabilizer would be a potential 
pharmacological target for preventing/attenuating the development of AAA (Tsuruda et al. 
2008; Sun et al. 2007).   
6. Conclusion 
Mast cells are predominantly present at the outer media and adventitia, and are susceptible 
to maturation/activation by interaction with cytokines in AAA tissues.  In addition, the 
mediators expressed by mast cells and neovascularization might contribute to enhance the 
inflammatory response in AAA.  These results underline the pathophysiological role of this 
type of immune cell in the development/progression of aneurysm formation.   
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